We’ve promised to keep you updated on how we’re progressing in our effort to develop Cancer Containment Therapy. To best understand our future progress, we’d like to give you a baseline of what we’ve accomplished so far.

To date, Remedy Plan has engineered a technology, or platform, that will allow us to measure the expression of several fluorescent proteins in cells. We engineered these cells to make these specific fluorescent proteins so that we could easily observe every time a specific piece of DNA gets used. The pieces of DNA we are interested in are the ones that are in action during the very early stages of our body’s development. These same pieces are what makes cancer cells spread through the body and multiply.

Through that platform we can identify drugs to see which ones can be used in cancer containment. So far, after testing a couple thousand drug candidates, we have identified several drugs that show promising capacity to block the spreading abilities of metastatic cells. The initial testing also helped prove that our technology really works to screen drugs. This is pretty important, especially to scientists who like to know that the assay (i.e. what we are measuring) is robust. Since this is an experimental system that will be used to test the applicability of hundreds of thousands of drugs, we need to know it is effective.

“Probably the most important thing that we did with our company’s wet lab work is to confirm that our technology can work as a really good drug screening platform. That doesn’t sound as exciting as talking about the potential drug candidates we found during that stage, but it’s a really crucial step in the scientific process,” said Remedy Plan CEO Greg Crimmins.

Much more testing is needed to follow up on these early results – and that’s where our crowdfunding campaign comes in. You can help us establish our lab and support the advancement of our research. The goal is to have over 100 drug candidates that we think are worth following up on before we move to the next step of testing them more vigorously in the lab for effectiveness and toxicity.

And then of course, that ultimate goal: finding a way to cure cancer.